... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Busulfan CML Acta haemat. 62: 119-120 (1979) Prolonged Busulfan-Induced Remissions in Chronic Myeloid Leukemia D. Benjamin, M. Djaldetti, Z. Mammon, M. Shaklai and J. Pinkhas...

... to in the content or advertisements. Busulfan CML Prolonged remission Acta haemat. 59: 354-359 (1978) A 13-Years Remission in Chronic M yelocytic Leukemia after a Single Course of Busulfan A. W einberger, D. Benjamin, D. D ouer, G. Barabash, M. Djaldetti and J. P inkhas Department of Medicine D...

...A. Caimo; C.M. Parodi; C. Rabitti; S. De Filippi; M. Podestà; A. Bacigalupo; A. Castellaneta; A.M. Marmont A new unusual translocation t (19p+; 22q-) was detected in a 31-year-old female with Philadelphia cromosome (Ph1) positive chronic myeloid leukemia (CML). This translocation has apparently...

...David Claxton; Hagop Kantarjian; Razelle Kurzrock; Jose M. Trujillo; Jordan U. Gutterman; Moshe Talpaz A patient whose chronic myelogenous leukemia (CML) was treated with interferon alpha (IFN-α) is described. The disease showed karyotypic evolution during the chronic phase and the later myeloid...

...Hayato Yamauchi; Ikuya Sakai; Hiroshi Narumi; Shinji Soga; Shigeru Fujita The mechanism of responsiveness of chronic myelogenous leukemia (CML) cells to interferon (IFN)-α was examined by using two subclones of CML cell line KT-1 which exhibited significantly different sensitivities...